In vivo Regeneration of Ganglion Cells for Vision Restoration

Rabies-virus system was used for trans-synaptic tracing of the MG-derived RGCs→dLGN→V1 pathway. (From BrainVTA)

The viruses used in this article from BrainVTA are in the table below

CRE Recombinase	AAV9-hSyn-Cre
Tracing Helper	PT-0023 AAV9-EF1α-DIO-RVG PT-0095 AAV9-EF1α-DIO-BFP-T2A-TVA
RV	RV-ENVA-ΔG-EGFP

Dongchang Xiao, Kangxin Jin, Suo Qiu, Qiannan Lei, Wanjing Huang, Haiqiao Chen, Jing Su, Qiang Xu, Zihui Xu, Bin Gou, Xiaoxiu Tie, Feng Liu, Sheng Liu, Yizhi Liu, Mengqing Xiang
Pub Date: 2021-10-04, DOI: 10.3389/fcell.2021.755544, Email: sales@brainvta.com

Glaucoma and other optic neuropathies affect millions of people worldwide, ultimately causing progressive and irreversible degeneration of retinal ganglion cells (RGCs) and blindness. Previous research into cell replacement therapy of these neurodegenerative diseases has been stalled due to the incapability for grafted RGCs to integrate into the retina and project properly along the long visual pathway. In vivo RGC regeneration would be a promising alternative approach but mammalian retinas lack regenerative capacity. It therefore has long been a great challenge to regenerate functional and properly projecting RGCs for vision restoration in mammals. Here we show that the transcription factors (TFs) Math5 and Brn3b together are able to reprogram mature mouse Müller glia (MG) into RGCs. The reprogrammed RGCs extend long axons that make appropriate intra-retinal and extra-retinal projections through the entire visual pathway to innervate both image-forming and non-image-forming brain targets. They exhibit typical neuronal electrophysiological properties and improve visual responses in RGC loss mouse models. Together, our data provide evidence that mammalian MG can be reprogrammed by defined TFs to achieve in vivo regeneration of functional RGCs as well as a promising new therapeutic approach to restore vision to patients with glaucoma and other optic neuropathies.

Figure 1. Initial, intermediate and terminal stages of MG trans differentiation induced by Math5 and Brn3b.

In this study, the authors provide evidence that mammalian MG can be reprogrammed by defined TFs to achieve in vivo regeneration of functional RGCs as well as a promising new therapeutic approach to restore vision to patients with glaucoma and other optic neuropathies.

BrainVTA offers viral vector construction & virus packaging services for AAV, LV, RABV, PRV, HSV and VSV that help researchers explore questions about genes, neurons, circuitry structure, function of brain network, mechanism and treatment of diseases.
If you have any needs, just email us at sales@brainvta.com.